Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association

Introduction. Subclinical hypothyroidism (ScH) is an endocrine alteration that is related to cardiovascular risk factors, including those categorized as components of the Metabolic Syndrome (MS). However, findings in prior reports regarding an association between these alterations are inconsistent....

Full description

Autores:
Bermúdez, Valmore
Salazar, Juan
Añez, Roberto
Rojas, Milagros
Estrella, Viviana
Ordoñez, María
Chacín, Maricarmen
Hernández, Juan Diego
Arias, Víctor
Cabrera, Mayela
Cano-Ponce, Clímaco
Rojas, Joselyn
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad Simón Bolívar
Repositorio:
Repositorio Digital USB
Idioma:
eng
OAI Identifier:
oai:bonga.unisimon.edu.co:20.500.12442/2456
Acceso en línea:
http://hdl.handle.net/20.500.12442/2456
Palabra clave:
Metabolic Syndrome
Hypothyroidism
Diabetes
Rights
License
Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
id USIMONBOL2_5bdf7874c47f7e5cd116681ccd603491
oai_identifier_str oai:bonga.unisimon.edu.co:20.500.12442/2456
network_acronym_str USIMONBOL2
network_name_str Repositorio Digital USB
repository_id_str
dc.title.eng.fl_str_mv Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
title Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
spellingShingle Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
Metabolic Syndrome
Hypothyroidism
Diabetes
title_short Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
title_full Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
title_fullStr Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
title_full_unstemmed Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
title_sort Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
dc.creator.fl_str_mv Bermúdez, Valmore
Salazar, Juan
Añez, Roberto
Rojas, Milagros
Estrella, Viviana
Ordoñez, María
Chacín, Maricarmen
Hernández, Juan Diego
Arias, Víctor
Cabrera, Mayela
Cano-Ponce, Clímaco
Rojas, Joselyn
dc.contributor.author.none.fl_str_mv Bermúdez, Valmore
Salazar, Juan
Añez, Roberto
Rojas, Milagros
Estrella, Viviana
Ordoñez, María
Chacín, Maricarmen
Hernández, Juan Diego
Arias, Víctor
Cabrera, Mayela
Cano-Ponce, Clímaco
Rojas, Joselyn
dc.subject.eng.fl_str_mv Metabolic Syndrome
Hypothyroidism
Diabetes
topic Metabolic Syndrome
Hypothyroidism
Diabetes
description Introduction. Subclinical hypothyroidism (ScH) is an endocrine alteration that is related to cardiovascular risk factors, including those categorized as components of the Metabolic Syndrome (MS). However, findings in prior reports regarding an association between these alterations are inconsistent. The purpose of this study was to determine the relationship between both entities in adult subjects from Maracaibo City, Venezuela. Materials and Methods. The Maracaibo City Metabolic Syndrome Prevalence Study is a descriptive, cross-sectional study with random and multistage sampling. In this substudy, 391 individuals of both genders were selected and TSH, free T3, and free T4 tests were performed as well as a complete lipid profile, fasting glycaemia, and insulin blood values. ScH was defined according to the National Health and Nutrition Examination Survey (NHANES) criteria: high TSH (≥4.12mUI/L) and normal free T4 (0.9-1,9 ng/dL) in subjects without personal history of thyroid disease. MS components were defined according to IDF/AHA/NHLBI/WHF/IAS/IASO-2009 criteria. A multiple logistic regression analysis was used to assess the relationship between MS components and ScH diagnosis. Results. Of the evaluated population, 10.5% (n=41) was diagnosed with ScH, with a higher prevalence in women (female: 13.6% versus male: 7.7%; χ2=3.56, p=0.05). Likewise, 56.1% (n=23) of the subjects with ScH were diagnosed with MS (χ2=4.85; p=0.03), being hyperglycemia the main associated criterion (χ2=11.7; p=0.001). In multivariable analysis, it was observed that the relationship was exclusive with the presence of type 2 diabetes mellitus (T2DM) OR: 3.22 (1.14-9.14); p=0.03. Conclusion. The relationship between ScH and MS in our population is dependent on the presence of hyperglycemia, specifically T2DM diagnosis, findings that vary from those previously reported in Latin American subjects.
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2019-01-18T21:17:56Z
dc.date.available.none.fl_str_mv 2019-01-18T21:17:56Z
dc.type.eng.fl_str_mv article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 16876334
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12442/2456
identifier_str_mv 16876334
url http://hdl.handle.net/20.500.12442/2456
dc.language.iso.eng.fl_str_mv eng
language eng
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
rights_invalid_str_mv Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
http://purl.org/coar/access_right/c_abf2
dc.publisher.eng.fl_str_mv Hindawi
dc.source.eng.fl_str_mv Advances in Pharmacological Sciences
institution Universidad Simón Bolívar
dc.source.uri.spa.fl_str_mv https://doi.org/10.1155/2018/8251076
bitstream.url.fl_str_mv https://bonga.unisimon.edu.co/bitstreams/8e446822-64cc-4535-ad59-b8849332c12f/download
https://bonga.unisimon.edu.co/bitstreams/9570b09f-277f-4fb7-8102-bfb2bf50fe28/download
https://bonga.unisimon.edu.co/bitstreams/d5cb2264-ba68-4d7b-ae7c-10b2f27da287/download
https://bonga.unisimon.edu.co/bitstreams/0bf82656-5625-45af-a442-e39648106655/download
https://bonga.unisimon.edu.co/bitstreams/bf83a782-983b-4b33-b7dc-d5b6bdffa5dd/download
https://bonga.unisimon.edu.co/bitstreams/2f700eb2-d39e-42f6-ba5d-879ae51d1961/download
bitstream.checksum.fl_str_mv 5d04bb7c40b5bd090235216b3963cc59
3fdc7b41651299350522650338f5754d
8695884535ad56fab7ecc901ceda069d
a1aca512a7b7ddfc1b85d9992afc52d6
baa3130b08010fa8769974e333fcd128
25b3657ac26caa0cb86a1c0ee164935c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Digital Universidad Simón Bolívar
repository.mail.fl_str_mv repositorio.digital@unisimon.edu.co
_version_ 1812100508410707968
spelling Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalhttp://purl.org/coar/access_right/c_abf2Bermúdez, Valmore29f9aa18-16a4-4fd3-8ce5-ed94a0b8663a-1Salazar, Juanfbd053e7-5aea-424c-812f-92153ecb9181-1Añez, Roberto0a8ecfdc-a89a-4435-9859-b66bba8947fa-1Rojas, Milagrosd07a9d4d-cce2-438c-b4a0-fc5ed4af1a67-1Estrella, Vivianac7dfd46f-673b-466f-8d5c-7fade3558a56-1Ordoñez, Maríae5acd06c-d456-4342-a815-e6ba46403d73-1Chacín, Maricarmen5c3b3d7c-4444-47e2-b2be-11f08df10409-1Hernández, Juan Diegod2e3538d-158e-424a-a3d4-37f5b19a238c-1Arias, Víctor791c1498-f0bf-44d3-b977-ea1985d9c11c-1Cabrera, Mayela4e4de10e-3518-4d4f-af50-42bc8e873f0a-1Cano-Ponce, Clímacof982571d-59d7-479a-926b-30f310523a5b-1Rojas, Joselyn2aa91570-0516-424d-8f76-25cd7b39be6e-12019-01-18T21:17:56Z2019-01-18T21:17:56Z201816876334http://hdl.handle.net/20.500.12442/2456Introduction. Subclinical hypothyroidism (ScH) is an endocrine alteration that is related to cardiovascular risk factors, including those categorized as components of the Metabolic Syndrome (MS). However, findings in prior reports regarding an association between these alterations are inconsistent. The purpose of this study was to determine the relationship between both entities in adult subjects from Maracaibo City, Venezuela. Materials and Methods. The Maracaibo City Metabolic Syndrome Prevalence Study is a descriptive, cross-sectional study with random and multistage sampling. In this substudy, 391 individuals of both genders were selected and TSH, free T3, and free T4 tests were performed as well as a complete lipid profile, fasting glycaemia, and insulin blood values. ScH was defined according to the National Health and Nutrition Examination Survey (NHANES) criteria: high TSH (≥4.12mUI/L) and normal free T4 (0.9-1,9 ng/dL) in subjects without personal history of thyroid disease. MS components were defined according to IDF/AHA/NHLBI/WHF/IAS/IASO-2009 criteria. A multiple logistic regression analysis was used to assess the relationship between MS components and ScH diagnosis. Results. Of the evaluated population, 10.5% (n=41) was diagnosed with ScH, with a higher prevalence in women (female: 13.6% versus male: 7.7%; χ2=3.56, p=0.05). Likewise, 56.1% (n=23) of the subjects with ScH were diagnosed with MS (χ2=4.85; p=0.03), being hyperglycemia the main associated criterion (χ2=11.7; p=0.001). In multivariable analysis, it was observed that the relationship was exclusive with the presence of type 2 diabetes mellitus (T2DM) OR: 3.22 (1.14-9.14); p=0.03. Conclusion. The relationship between ScH and MS in our population is dependent on the presence of hyperglycemia, specifically T2DM diagnosis, findings that vary from those previously reported in Latin American subjects.engHindawiAdvances in Pharmacological Scienceshttps://doi.org/10.1155/2018/8251076Metabolic SyndromeHypothyroidismDiabetesMetabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Associationarticlehttp://purl.org/coar/resource_type/c_6501P. B. Nolan, G. Carrick-Ranson, J. W. Stinear, S. A. Reading, and L. C. Dalleck, “Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis,” Preventive Medicine Reports, vol. 7, pp. 211–215, 2017. View at Publisher · View at Google Scholar · View at ScopusA. P.Delitala, G. Fanciulli, G. M. Pes, M.Maioli, and G.Delitala, “Thyroid hormones, metabolic syndrome and its components,” Endocrine, Metabolic & Immune Disorders—Drug Targets, vol. 17, no. 1, pp. 56–62, 2017.K. Esposito, P. Chiodini, A. Colao, A. Lenzi, and D. Giugliano, “Metabolic syndrome and risk of cancer: a systematic review and meta-analysis,” Diabetes Care, vol. 35, no. 11, pp. 2402–2411, 2012.A. Cuevas, V. Álvarez, and F. Carrasco, “Epidemic of metabolic syndrome in Latin America,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 18, pp. 134–138, 2011.M. I. Surks, E. Ortiz, G. H. Daniels et al., “Subclinical thyroid disease: scientific review and guidelines for diagnosis and management,” Journal of the AmericanMedical Association, vol. 291, no. 2, pp. 228–238, 2004.C. Chang, Y. Yeh, J. L. Caffrey, S. Shih, L. Chuang, and Y. Tu, “Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism – A Cohort Study,” Scientific Reports, vol. 7, no. 1, 2017.C. S. Fox, M. J. Pencina, R. B. D’Agostino et al., “Relations of thyroid function to body weight: Cross-sectional and longitudinal observations in a community-based sample,” JAMA Internal Medicine, vol. 168, no. 6, pp. 587–592, 2008.V. Bermúdez, R. P. Marcano, C. Cano et al., “The maracaibo city metabolic syndrome prevalence study: design and scope,” American Journal of Therapeutics, vol. 17, no. 3, pp. 288–294, 2010.World Health Organization, “Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity,” Geneva: The Organization (WHO Technical Report Series, No. 894), 2000.Centers for Disease Control and Prevention, “NHANES - NHANES III - Reports and Reference Manuals,” http://www .cdc.gov/nchs/nhanes/nh3rrm.htm.K. G. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009.J. G. Hollowell, N. W. Staehling, W. D. Flanders et al., “Serum TSH, T4, andThyroid Antibodies in the United States Population (1988 to 1994): NationalHealth and Nutrition Examination Survey (NHANES III),”The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 489–499, 2002.V. Bermudez, J. Rojas, M. S.Martinez, and etal., “Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for HomeostasisModel Assessment-2 Insulin Resistance: A Report fromaVenezuelan Population,” International Scholarly Research Notices, vol. 2014,Article ID 616271, 2014.American Diabetes Association, “Standards of medical care in diabetes—2017: summary of revisions,” Diabetes Care, vol. 40, Supplement 1, pp. S4–S5, 2017.B. Biondi and D. S. Cooper, “The clinical significance of subclinical thyroid dysfunction,” Endocrine Reviews, vol. 29, no. 1, pp. 76–131, 2008.J. D. J. Garduño-Garcia, U. Alvirde-Garcia, G. López-Carrasco et al., “TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects,” European Journal of Endocrinology, vol. 163, no. 2, pp. 273–278, 2010.M. M. Pesic,D.Radojkovic, S.Antic,R.Kocic, andD. Stankovic- Djordjevic, “Subclinical hypothyroidism: Association with cardiovascular risk factors and components of metabolic syndrome,” Biotechnology & Biotechnological Equipment, vol. 29, no. 1, pp. 157–163, 2015.S. Khatiwada, S. K. Sah, R. KC, N. Baral, and M. Lamsal, “Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome,” Clinical Diabetes and Endocrinology, vol. 2, no. 1, 2016.A. Ogbera, O. Dada, and S. Kuku, “The metabolic syndrome in thyroid disease: A report from Nigeria,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 3, p. 417, 2012.M. Uzunlulu, E. Yorulmaz, and A. Oguz, “Prevalence of subclinical hypothyroidism in patients with metabolic syndrome,” Endocrine Journal, vol. 54, no. 1, pp. 71–76, 2007.C. Wang, “The Relationship between Type 2 Diabetes Mellitus and RelatedThyroidDiseases,” Journal of Diabetes Research, vol. 2013, Article ID 390534, 9 pages, 2013.L. Chaker, S. Ligthart, T. I. M. Korevaar et al., “Thyroid function and risk of type 2 diabetes: A population-based prospective cohort study,” BMC Medicine, vol. 14, no. 1, 2016.S. Furukawa, S. Yamamoto, Y. Todo et al., “Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetesmellitus,” Endocrine Journal, vol. 61, no. 10, pp. 1011–1018, 2014.C. Han, X. He, X. Xia et al., “Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis,” PLoS ONE, vol. 10, no. 8, Article IDe0135233, 2015.M. Hage, M. S. Zantout, and S. T. Azar, “Thyroid disorders and diabetes mellitus,” Journal ofThyroid Research, vol. 2011, Article ID 439463, 7 pages, 2011.A. Cabanelas, P. C. Lisboa, E. G. Moura, and C. C. Pazos Moura, “Leptin acutemodulation of the 5 -deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats,” Hormone and Metabolic Research, vol. 38, no. 8, pp. 481–485, 2006.S. Topsakal, E. Yerlikaya, F. Akin, B. Kaptanoglu, and T. Er¨urker, “Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome,” Eating and Weight Disorders, vol. 17, no. 1, pp. e57–e61, 2012.C. Han, C. Li, J. Mao, and etal., “High Body Mass Index Is an Indicator of Maternal Hypothyroidism, Hypothyroxinemia, andThyroid-Peroxidase Antibody Positivity during Early Pregnancy,” BioMed Research International, Article ID 351831, 2015.E. Maratou, D. J. Hadjidakis, A. Kollias et al., “Studies of insulin resistance in patients with clinical and sub clinical hypothyroidism,” European Journal of Endocrinology, vol. 160, no. 5, pp. 785–790, 2009.H. J. Baskin, R. H. Cobin, D. S. Duick et al., “American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism,” Endocrine Practice, vol. 8, no. 6, pp. 457– 469, 2002.E. Bilic-Komarica, A. Beciragic, and D. Junuzovic, “Effects of treatment with L-thyroxin on glucose regulation in patients with subclinical hypothyroidism,” Medical Archives, vol. 66, no. 6, pp. 364–368, 2012.H. Méndez Castellano and M. C. de Méndez, “Estratificación social y biología humana: método Graffar modificado,” in Arch Ven Pueric Pediatr, vol. 49, pp. 93–104, 1986.V. Bermúdez, M. Cabrera, C. Chavez et al., “Comportamiento epidemiol´ogico del hipotiroidismo subclínico y su asociación con factores de riesgo cardiometab´olicos en individuos adultos del municipioMaracaibo, Venezuela,” Revista Latinoamericana de Hipertensión, vol. 8, no. 1, pp. 1–8, 2013.M. V´azquez, J. Rojas, and V. Bermudez, “Comportamiento epidemiológico del hipotiroidismo en pacientes con diabetes mellitus tipo 2 en la ciudad de Loja – Ecuador,” Revista Latinoamericana de Hipertension, vol. 8, no. 4, pp. 95–102, 2013.ORIGINALPDF.pdfPDF.pdfPDFapplication/pdf1649208https://bonga.unisimon.edu.co/bitstreams/8e446822-64cc-4535-ad59-b8849332c12f/download5d04bb7c40b5bd090235216b3963cc59MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-8368https://bonga.unisimon.edu.co/bitstreams/9570b09f-277f-4fb7-8102-bfb2bf50fe28/download3fdc7b41651299350522650338f5754dMD52TEXTMetabolic Syndrome and Subclinical Hypothyroidism.pdf.txtMetabolic Syndrome and Subclinical Hypothyroidism.pdf.txtExtracted texttext/plain34505https://bonga.unisimon.edu.co/bitstreams/d5cb2264-ba68-4d7b-ae7c-10b2f27da287/download8695884535ad56fab7ecc901ceda069dMD53PDF.pdf.txtPDF.pdf.txtExtracted texttext/plain35737https://bonga.unisimon.edu.co/bitstreams/0bf82656-5625-45af-a442-e39648106655/downloada1aca512a7b7ddfc1b85d9992afc52d6MD55THUMBNAILMetabolic Syndrome and Subclinical Hypothyroidism.pdf.jpgMetabolic Syndrome and Subclinical Hypothyroidism.pdf.jpgGenerated Thumbnailimage/jpeg1569https://bonga.unisimon.edu.co/bitstreams/bf83a782-983b-4b33-b7dc-d5b6bdffa5dd/downloadbaa3130b08010fa8769974e333fcd128MD54PDF.pdf.jpgPDF.pdf.jpgGenerated Thumbnailimage/jpeg5245https://bonga.unisimon.edu.co/bitstreams/2f700eb2-d39e-42f6-ba5d-879ae51d1961/download25b3657ac26caa0cb86a1c0ee164935cMD5620.500.12442/2456oai:bonga.unisimon.edu.co:20.500.12442/24562024-07-26 03:10:02.706open.accesshttps://bonga.unisimon.edu.coRepositorio Digital Universidad Simón Bolívarrepositorio.digital@unisimon.edu.coPGEgcmVsPSJsaWNlbnNlIiBocmVmPSJodHRwOi8vY3JlYXRpdmVjb21tb25zLm9yZy9saWNlbnNlcy9ieS1uYy80LjAvIj48aW1nIGFsdD0iTGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyIgc3R5bGU9ImJvcmRlci13aWR0aDowIiBzcmM9Imh0dHBzOi8vaS5jcmVhdGl2ZWNvbW1vbnMub3JnL2wvYnktbmMvNC4wLzg4eDMxLnBuZyIgLz48L2E+PGJyLz5Fc3RhIG9icmEgZXN0w6EgYmFqbyB1bmEgPGEgcmVsPSJsaWNlbnNlIiBocmVmPSJodHRwOi8vY3JlYXRpdmVjb21tb25zLm9yZy9saWNlbnNlcy9ieS1uYy80LjAvIj5MaWNlbmNpYSBDcmVhdGl2ZSBDb21tb25zIEF0cmlidWNpw7NuLU5vQ29tZXJjaWFsIDQuMCBJbnRlcm5hY2lvbmFsPC9hPi4=